INTENSITY THERAPEUTICS, INC. Proceeds from Common Stock Issued
INTENSITY THERAPEUTICS, INC. (INTS) reported Proceeds from Common Stock Issued of $345.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-05-13
- INTENSITY THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $345.00K.
- INTENSITY THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2024-03-31 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 9 month |
|---|---|---|
| 2025-03-31 | $345.00K 10-Q · filed 2025-05-13 | |
| 2024-09-30 | $232.00K 10-Q · filed 2024-11-13 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |